ID: ALA3228388

Max Phase: Preclinical

Molecular Formula: C7H8BrF3N2

Molecular Weight: 176.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.N=c1ccccn1CC(F)(F)F

Standard InChI:  InChI=1S/C7H7F3N2.BrH/c8-7(9,10)5-12-4-2-1-3-6(12)11;/h1-4,11H,5H2;1H

Standard InChI Key:  UPMNWMHVXPWAEM-UHFFFAOYSA-N

Associated Targets(non-human)

INMT Indolethylamine N-methyltransferase (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 176.14Molecular Weight (Monoisotopic): 176.0561AlogP: 1.53#Rotatable Bonds: 1
Polar Surface Area: 28.78Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.89CX LogP: 1.36CX LogD: -1.02
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.67Np Likeness Score: -1.31

References

1. Rokach J, Hamel P, Hunter NR, Reader G, Rooney CS, Anderson PS, Cragoe EJ, Mandel LR..  (1979)  Cyclic amidine inhibitors of indolamine N-methyltransferase.,  22  (3): [PMID:423205] [10.1021/jm00189a004]

Source